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Executive Summarv
This second report on the integration of health requirements in Community
policies gives an overview of Community activities in 1995 with repercussions on
health. Building on the first report, published in 1995, which took stock of health
dimensions in all areas of Community policy, this report concentrates on a number
of key policy areas. It is in these areas that the most important health-related
developments have taken place:
- social policy,
- internal market,
- agriculture, food and fisheries,
- research and developmen!
- environment and energy,
- transport,
- international cooperation.
It includes the work of relevant agencies and other outside bodies connected to
the Community which are working in these areas.
This annual report is one of the instruments the Commission has set up in order
to monitor how the Community is meeting the obligation in Article 129 of the
Treaty that health requirements shall form a constituent part of other Community
policies. As set out in detail in the first report in 1995, this Treaty obligation is
supplemented by a range cif other references to health protection in the context of
other Community policies. Their common aim is to ensure a high level of human
health protection (Article 3 (o) of the Treaty).
In the light of this goal, the Commission has also put into place other instruments
which have more influence on the preparation of Community legislation and other
activities than a retrospective report. These include the procedures of full
interservice consultation on proposals in other fields which could have an impact
on health being put forward by the Commission. In addition, the Interservice
Group on Health provides opportunities for more general discussions of health-
related topics among Commission services, while ad hoc groups have been created
to allow more detailed examinations of particular problems or areas of policy
from the health point of view.
Some progress has been made in raising awareness of the numerous links with
and effects on health which the vast majority of Community policy areas have -
and therefore of the importance of an early integration of health issues into the
preparatory work for drawing up policies and action programmes - both within the
Community institutions as well as in Member States. Moreover, the fact that
health issues also tend to generate considerable media attention and raise major
concerns among the population is another reason why they need to be taken into
account at an early stage of policy formation.
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It is not always evident how best to inltegrate health requirements in a given area
of policy, or how and according to which criteria to judge success or failure.
Work will have to continue to develop thinking on these areas. In publishing this
report, the Commission wishes to stirnrulate public debate on these questions. In
this sense, this report is an instrument 1lo promote transparency and discussion on
health issues within the Community.
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fntroduction
This second report on the integration of health requirements in Community
policies aims to provide an overview of developments in European Community
policy pertaining to health. Read as a whole, it shows that a wide range of policy
areas in the Community have considerable repercussions on health,
Article 129 of the Treaty stipulates that health considerations should form a
constituent part of the Community's other policies. This annual report - following
a Commission decision in the context of adopting the Commission
Communication on the Framework of Action in the field of public healthr - is
designed to give an overview on how this obligation of the Treaty is taken into
account in the different areas of Community policy.
This report is supplemented by other instruments of consultation and concertation
within Commission services which aim to ensure that health reQuirements are
properly taken into account. An Interservice Group on Health has been created
which includes representatives frorn relevant Commission services and meets in
plenary several times a year. Several- subgroups follow specific issues. In
application of regular Commission internal procedures, Commission services are
required to consult on all proposals with a potential bearing on health with the
responsible services for public health in the Directorate General for Employment,
Industrial Relations and Social Affairs.
The first report on the integration of health requirements in other Community
policies, covering activities in 1994, was adopted by the Commission on 29 May
19952. As a first report of its kind, it aimed to give a complete overview of
Community activities related to health. This second report focuses on health-
related activities during the course of 1995. It does not include the recent debates
on BSE and CJD which occurred in 1996 and will be dealt with in the third
report. For a broader picture, it should be read in conjunction with the first report,
particularly with its introduction, which includes a history of health-related
activities at Community level.
The first report was met with great interest by the other Community Institutions
and the public, while there was recognition of the difficulties associated with
presenting such a wide range of topics in a coherent manner. The Council adopted
a resolution on the integration of health requirements in Community policies
which took the 1994 report as a point of departure.
The Council welcomed the initiative taken by the Commission to present such
reports, and invited the Commission to pay particular attention, in future reports,
to certain 6reas of Community activity, namely, economic and in particular fiscal
policy, social policy, including questions of employment, free movement of goods
and persons, agricultural and food policy, consumer policy, research and
technological development, environment and transport.3
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This report seeks to present an overview of all relevant activities whilst giving
particular attention to the abovementiorred areas of policy.
The European Parliamen! in its Resolution on the medium-term social action
progftrmme, asked the Commission to present guidelines on incorporating health
protection requirements in the other Community policiesa.
This year's report starts offwith an overview of the public health programmes and
activities of the Community, which in 1995 have been advanced considerably.
This is followed by a summary of activities in a number of priority areas - areas
which are important either because of the major activities which took place last
year or because of the major impact they have on health in general. In a third
section, the report outlines other health-related activities in additional areas of
Community policy. In addition, some specific subjects (drugs, AIDS and tobacco)
are presented in "boxes" inserted into the text. Legislative measures proposed or
adopted in 1995 are summarised in an ,annex.
As in the first report, this report demonstrates that there is a diversity of areas of
activity with an impact on health in the Community. In some areas, a remarkable
degree of coherence has been achieved between the objectives in their own right
and their impact on public health. In other areas, there is still progress to be made.
This report is designed to present as broad a picture as possible of political
initiatives with a health perspective. It r;ould serve to raise awareness on health-
related issues and their likely impact, as well as to stimulate efforts aimed at
ensuring that health becomes a fundamental consideration in the design and
implementation of policies.
Report on the Medium-Term Social Action Programme (I{UGIIES), Doc. A,443lll95,p. 12
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Public health programmes and activities
The Commission's Communication on the Framework of Action in the field of
public healthi identified eight policy areas necessitating particular attention and
the development of specific programmes. As outlined in the 1994 report, proposals
have been presented in the areas of the frght against cancer (Proposal for a
European Parliament and Council Decision adopting an action plan 1996-2000 to
combat cancer6), prevention of AIDS and other communicable diseases (Proposal
for a European Parliament and Council Decision adopting a Community action
p.ogrornrn" on the prevention of AIDS and other communicable diseasesT),
prevention of drug dependence @roposal for a European Parliament and Council
Decision adopting a progr4mme of Community action on the prevention of drug
dependencet; and health promotion, information, education and training (Proposal
for a Europeari Parliament and Council Decision adopting a programme of
Community action).
On the programmes on cancer, AIDS and other communicable diseises, and
health promotion, agreement was reached in the Conciliation Committee between
Council and the European Parliament in December 1995 which led to the adoption
of the relevant decisions in 1996. The Council adopted a Common Position on the
Community action on drug dependence in December 1995t0.
In October 1995, the Commission adopted a Communication and Proposal for a
Community action programme on health monitoringrr, which aims at developing
a framework for the establishment of common health indicators among Member
States and should establish a comparable basis for collecting and evaluating health
data in the Community.
In addition to the 1994 report on the integration of health requirements in
Community policies, the Commission adopted in July 1995 the first Report on the
State of Health in the European Communityt', which gives an overview of health
status in the Community, including a description of the main demographic trends
and patterns of mortality and morbidity as well as the major determinants of
health. The Commission intends to present annual health status reports, focusing
on specific issues and population groups. At regular intervals, a general health
status report will be produced.
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13. In the context of its activities in the lireld of cancer prevention in 1995, the
Commission supported the European Week against Cancer intended, notably, to'
promote the European Code against Cancer, a set of l0 simple but essential
cancer prevention recommendations established by Europe's leading cancer
experts.
During the weelc, a campaign aiming at the widest possible dissemination of the
Code was carried out in all Member States, in close collaboration with
organisations working in the field. Ttre campaign was based on a common
European concept and common supportirrg material (posters, leaflets, video spots,
advertisements). 6.5 million information leaflets on the Code were distributed, and
more than 250 million contacts were achieved through articles in the press and TV
features as well as through (free) advertising space.
In pardlel, a brochure on the Code was prepared geared to the particular
information requirements of general practitioners, who play a vital role in raising
their patients' awareness of the possibilities for cancer prevention; this brochure
was mailed to all of Europe's 325 000 GPs and was widely welcomed.
Mental healrh
In 1995, the specific Community action providing exceptional financial support
for Greece inter alia in the field of mental health from the European Social Funds
was concluded. This was the first CommLunity involvement in the field of mental
health. The operations, involving 60 million ecus over eleven years, were designed
to deal with the need to reform the Grrsek psychiatric care system through the
development across the country of new s'fructures and services aimed at the social
and vocational rehabilitation of mentally.ill and mentally handicapped persons and
the improvement of care conditions for patients in public psychiatric hospitals.
The impact of the programme has been significant. It led to the dqvelopment of
a structure for psychosocial rehabilitation services in Greece as well as a reduction
in the size of the large psychiatric centres and hospitals and an improvement in
the conditions {bund therer3.
cf. Final report, COM (95) 668 fin. of 15.12.199t5
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3. Integration of health requirements in Community policies
3.1 Social policy
15. Social and health policies are linked in many ways. Questions of employment and
unemploymeng labour laws, social protection systems and insurance, policy
towards specific marginalised or vulnerable groups and regulations on health and
safety at work all have broad repercussions on health.
The main orientation document for the Community's sobial policy is the Medium-
Term Social Action Programme 1995-199714, which defines the creation of jobs
and the fight against unemployment as the main priority of Community action.
A number of areas of social policy have a particular health dimension, i.e. the
future of social protection, questions of solidarity and social exclusion, disability,
questions of migration and of workers' mobility inside the Community, as well as
the very concrete concerns on health and safety at work.
3.1.1 Social protection
16. In the debate on future orientations of social policy, social protection plays a
central role. On 3l October 1995, the Commission adopted its Communication
"The fufure of social protection - a framework for a European debate"rs, which
identifies social protection as a fundamental component and a distinguishing
feature of European societies. This is a contribution to the European debate on the
future of social protection in the light of demographic changes as well as the
economic and social challenges Europe is facing. An important factor in this
debate is the future of health care systems, wheie the Community can help to
exchange experiences on how to reconcile the objective of providing universal
access to all necessary health care and prevention facilities with the need to
contain rising costs.
Reforms in health care are also a specific topic in the report on social protection
in Europer6, which reports on the developments in this area in Member States.
3.1.2 European Social Fund
17. As outlined in the previous report, the European Social fund ,upports projects
both to encourage active measures in the labour market as well as to improve the
general conditions for developing the full potential of participants in the labour
market. Operations under Community Support Frameworks (CSFs) agreed with
the Commission have started in the Member States. Results from the evaluation
of these piojects will be presented in later reports.
l4
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Social protection in Europe, 1995
lg. A first set of projects was selected for the Community Initiative "Employment"
in December tggS and will be canried out over the coming years. The
Employment programme includes initiatives on the integration of people with
aisaUitities (I{ORIZON) and people froim excluded backgrounds (INCLUSION)
into the labour market. In both initiatives, a number of projects selected involve
a health dimension.
19. A certain amount of funds was set asicle from general Social Fund financing to
support innovative measures to achieve a more employment-intensive pattern of
gro*th, to improve the workings of the tabour market and to reinforce the training
system. This includes specific measurers for groups in danger of exclusion from
the labour market. Of the more than 6l) projects selected in 1995, four projects
were particularly related to health, covering the integration of physically disabled '
peopll, health informatics and adapted workplaces for people with disabilities.
3.1.3 Solidarity - social exclusion
20. Health and social exclusion are inextricably linked. Poor health can be the cause
of social exclusion (e.g. in the case in chronic sickness or invalidity leading to
long-term unemployment, or in the case of the stigmatisation of a chronically ill
or disabled person); it can be the consequence ofsocial exclusion (e.g. depression,
psychosomatic illness); it can be part oll social exclusion (e.g. unhealthy housing,
iu"t of pnning water, of accessible toilets, of a well-balanced diet, of access to
quality health-services), or it can be a factor preventing reintegration (e.g.
depression, psychosomatic illness, lack of self-confidence if the person's physical
health is weakened). Social exclusion may make access to health services more
difficult.
21. The scheme of European funding firr projects seeking to overcome social
exclusion (1995) received some 2000 aprplications, many of which were concerned
with different aspects of health. The asp'ects most frequently included were : drug
and alcohol abuse, mental health and well-being (particularly of immigrants and
refugees), disability (both mental and physical). Of the 86 projects finally adopted
in Decernber 1995, 15 concerned hr:alth, touching on the following areas:
drug/alcohol addiction (8 projects), integration of sick and healthy people in
houiing development (2), help for women who have experienced violence (2),
information about health services in innmigrants' own languages (1), integration
of prostitutes (2), integration of schizophrenics and their carers (l), improvement
of mental health and well-being (1).
22. The European Initiative for the Prevention of Urban Delinquency and the Social
Reintegraiion of Ex-Offenders (1995) included numerous health-related projects,
in particular as regards drug abuse. Dnrg abuse is a health problem needing to be
tackled among potential delinquents, and/or prisoners or ex-offenders. But it is
also in many cases a crime itself, and often a major cause of further crime.
6
3.1.4 Free movement of workers
23. On 28 June 1995, the Commission submitted a proposal for a Council Regulation
amending Regulation (EEC) l4}8l71f7.In particular, this proposal provides that
the entitlement to urgently needed health care of a person who is insured in one
Member State and temporarily resident in another be extended to all persons
regardless of their nationality.
3.1.5 People with disabilities
24. As in health matters, policies concerning disabled people are tending increasingly
to move away from strictly medical considerations towards the area of social
welfare. While it is still important to look at how disabilities develop and at ways
of preventing them, it is now essential to have a better understanding of their
social effects. In this conneetion, we are now seeing the emergence of a new
approach based on the need to take action directed not only at disabled individuals
but also at the environment in which they live.
The third Community Action Programme to assist disabled people (IIELIOS [)r8,
covering the period fanuary l993-December 1996, is in line with this approach
in that it develops exchanges and disseminates information at Community level
so as to promote equality of opportunity for the disabled. Activities taking place
under the programme in 1995 mainly concerned the following areas: anti-
discrimination measures, raising public awareness, independent living, the creation
of suitable jobs, and the role of NGOs.
3.1.6 Health and safety at work
25. The Communication from the Commission on a Community programme
concerning safety, hygiene and health at work (1996-2000) was adopted on
12 July l995re, and included a proposal for a Council decision adopting a
programme of non-legislative measures to improve health and safety at work.
The Commission intends that this programme should provide a sufficiently
flexible, dynamic and realistic framework to enable the Community to meet the
challenges posed by the profound economic, technological and social changes that
are occurring. It includes non-legislative measures, a legislative programme and
provisions concerning health and safety in other policies. As part of the
programme the Commission has included SAFE (Safety Action for Europe),
aimed at improving safety, hygiene and health at work especially in small and
medium-sized enterprises.
t7
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Amended proposal for a Council Regulation of 28.06.1995, OJ C 242 of 19.09.1995
Council Decisirrn of 25.02.1993 establishing a third Community Action programme to promote
equal opportunities and the integration of disabled people (I{ELIOS fi), 93/1361ffiC, OJ C 56,
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The proposed decision of the Commisrsion deals with the development of non-
legislative measures such as guidance notes and information, education and
training malerial and the SAFE programme
In setting Occupational Exposure Limits (OELs) for the control of exposure to
chemical substances the aim is to identifu a level of exposure at which, according
to the most up-to-date knowledge, the exposed worker's health should not be
affected.
To further support the work of develc,ping harmonized OELs, the Commission
Decision on setting up a Scientific Connmittee for Occupational Exposure Limits
to Chemical Agents (SCOEL)'z0 estatrlished a formal basis for the scientific
evaluation of the risk at the workplace related to chemical substances. By giving
the Committee a formal basis, the Eurropean Commission has acknowledged the
work already performed and significantly advanced its role in the European
process, contributing to the global aim on the harmonisation of conditions in the
working environmenf as specified by,Article 1l8a of the European Ctimmunity
Treaty.
In September 1995 the Commission presented a proposal for a Council Directive
amending for the first time Directive 901394/EEC on the protection of workers
fronr the risks related to exposure to caucinogens at work.2r The main purpose of
this proposal is to set limit values for occupational exposure to carcinogens,
starting 
.with trenzene.
On 29 June 199522 the Council adopted a Regulation which amended the
Regulation establishing a European t\gency for Safety and Health at Work,
located in Bilbao. The Agency's main tasks will be to collect and disseminate
technical, economic and scientific information on health and safety at work and
to promote and support exchanges of infbrmation and experience between Member
States.
The Agency became operational in 1995. Two meetings of its Administrative
Board were held. The recruitment of staff began with the publication of the Call
for ,Applications for the post of Director23.
In July 1995, the Commission decided to officially set up the Committee of Senior
Labour Inspectors (SLIC)24, which has existed informally since 1982. In 1995, the
Committee discussed inter'alia issues of free movement of workers, services and
enterprises engaged in health and sa:[ety, and informatics support for labour
inspectorates. SLIC has agreed on common principles of labour inspection. A
process of evaluation of national systems was launched on the basis of these
principles Observers from Central and Eastern European countries and the Baltic
States participated in parts of the Committee meetings.
Commission Decision 95/320/EC of 12.07.199t5 - O.J. N" L 188, 9.8.1995
o.J. No c 317,28.11.1995
Council Regulation N' 1643/95, OJ N' L 156,07.07.1995, p.l
oJ N. i 338, 16.12.199s
Comnrission Decision 95/319/EC of 12.07.195t5, OJ L 188/l l, 09.08.1995
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Actions to combat drug dependence focus on reducing the supply of drugs
(through measures such as police cooperation and border controls and
incentives to producers to grow alternative crops) and on addressing the
problems of drug users (through health and social support measures). Both
approaches are prominent in the Community actions in the drugs sector, and
are combined in the Community Action plan to combat drugs (1995-99)2r.
The reduction of drug dependence is a priority area for Community activities
in the field of public health and is specifically mentioned in Article 129 of
the Treaty. A corresponding Community action programme is currently
under discussion. This is supplemented by high profile events, such as
European'Weeks against Drug Dependence.
Social policy actions'aimed at marginalised groups in society also reinforce
preventive and support activities concerning potential and actual drug users.
These actions are supplemented by other activities, e.g. research, education
and *aining activities (particularly aimed at young people). Another
important area is medicinal products, where issues of dependence are raised.
Drug supply reduction and activities preventing drug traffrcking often extend
beyond the territory of the Community and are therefore conducted in
cooperation with third countries and international organisations. These issues
are covered in several programmes of cooperation with third countries, e.g.
Tacis/ Phare and the Lom6 convention.
Internally, drug supply reduction is a major topic in the area of cooperation
between Member States in judicial and home affairs, particularly concerning
police cooperation. Implementation of the first phase of EUROPOL also
covers this topic.
The Community is supporting relevant activities by the United Nations, its
agencies and other international organisations.
See the relevant sections of thts report for further information on 1995
activities in these areas of policy.
J.
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Internal market -.free movement of persons and goods, tmation
Community activities regarding the creation of the internal markei have numerous
consequences f6r health. These include the development of common rules and
regulations concerning the markets for specific products, e.g. pharmaceuticals or
medical devices, as well as the rules on free movement of goods as such. A
25 COM (94) 234 frn.
specific area of activity - under the auspices of consumer protection - is the field
of cosmetics. Indirect ta,xation of goodls such as tobacco or alcohol can have
immediate health effects. An important requisite enabling the free movement of
persons is the recognition of diplomas, e.g. in medical professions. Finally, data
protection is an area of Community policy where health-related concerns - both
of the citizen interested in protecting his/her medical and other data and the
medical researcher - need to be taken into account.
3.2.1 Medicinal products
31. Starting with the first directive in 1965, Community legislation on pharmaceuticals
has usually been designed to prornote and protect public health. By 1993 there
was a harmonised legal framework for nnarketing authorisations. Under the rules,
every medicinal product must meet strict quality, safety and effrcacy criteria
before it can be authorised. This legislation covers all industrially-manufactured
medicinal products: vaccines, blood products, radiopharmaceuticals. The criteria
are regularly revised to take account of scientific and technical progresl.
1995 saw the introduction of the nevu European system for authorising and
monitoring medicinal products in the European Community. Under this new
system the Commission has already authorised the marketing of three innovative
products.
This new system for registering medicinal products in the European Community
represents a decisive step towards the establishment of the Single Market. It helps
to promote the free movement of meclicines within the European Community
while ensuring optimum protection for public health. r
32. The main innovation in this area in 19915 was the establishment of the European
Medicines Evaluation Agency (Etn{EA) in London, whose aim is to encourage
cooperation between, and coordinate the resources of; national drug registration
agencies.
There are now two licensing procedures for medicinal products: a centralised
procedure, which is compulsory for high-technology products and optional for
innovatory new medicines, and a decerntralised procedure that is based on the
principle of mutual recognition of national authorisations. Under the latter
procedure, the Agency intervenes if ther:e are conflicting scientific evaluations by
national authorities when applicatiorr is made for mutual recognition of
authorisations.
Once the evaluation process has been completed, the European Commission is
responsible for making the scientific opinions binding (for human and veterinary
uses).
This new system provides all patients in the European Community with more
rapid, and simultaneous, access to innovatory medicines. When an authorisation
is issued, health professionals and consllmers are provided with clear and reliable
information in the form of labels and package leaflets. In addition, the monitoring
of medicinal products after their authorisation is being improved through
coordination by the Agency of national pharmacovigilance activities.
l0
By coordinating national resources devoted to drugs registration, this system helps
to ensure that the qudity, safety and eflicacy of medicines which are to be
marketed in the European Community or exported to third countries are of an
optimum standard.
Finally, this system coincides with the emergence of the European Community
onto the international scene. It provides third countries with a public health
guarantee for evaluations canied out in the Community and strengthens the latter's
position vis-i-vis these countries.
33. In 1995, the institutions discussed the Communication from the Commission to
the Council and the European Parliament on the outlines of an industrial policy
for the pharmaceutical sector in the European Communityr. Although in other
areas the Commission advocates a global approach to industrial policy, a sectoral
aplroach seemed appropriate in this particular area given the public health and
social policy issues that it raises. In its communication, the Commission proposes
a set of guidelines reconciling effective control of health care expenditure with
continuation of the long-term efforts by thO European pharmaceutical industry to
develop therapeutically innovative medicines. Howeveq it is the Council which
should take the lead here since most of the subjects discussed in the Commission's
communication lie within the competence of the Member States.
34. The Commission has launched an information society programme for the
pharmaceutical sector to encourage transparency and the rapid exchange of
information. This is particularly important as regards pharmacovigilance. The
databases to which the network will give access will include scientific and
economic information on all medicines sold on the Community market.
3.2.2 Medical devices
Community legislation on medical devices removes technical barriers to trade,
thus enabling the single market to be brought about in this particular sector. It is
also designed to ensure a high level of safety and health in the Community and,
for this purpose, introduces a c'oherent approach to the establishment and
implementation of requirements for the design, manufacture and marketing of such
devices. The gains in terms of protection of public health are real and quite
considerable.
I January 1995 saw the compulsory application - following the end of the
transition period - of Council Directive 90/385/EEC on active implantable medical
devices. It also marked the optional application - at the beginning of the transition
period - of Council Directive 93l42tEEC, which covers all other medical devices
(except th6se used for in vitro diagnosis). During 1995, the Commission's efforts
aimed at implementing these two directives had a positive effect as regards the
protection of public health. Its activities included:
- consultations with authorities in the Member States which are responsible
for implementing the two directives;
35.
36.
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coordination and monitoring of the activities of the certification bodies
concerned (notified bodies) to ensure that the latter adopt a uniform,
consistent approach2T
monitoring performance of the tasks assigned to international
standardisation organisations (CIIN and CENELEC). In this connection,
the titles and references of important "horizontal" standards have been
pubtished in the OJ, giving them the status of European harmonised
standards2t
encouraging and coordinating work to set up a Community monitoring
system so as to avoid the occurrence and/or reculTence of events with
negative repercussions on public health; in 1995, the issuing of public
warnings concerning certain types of devices and the use of the safeguard
clause by certain Member states, as provided for in the directives, showed
how valuable and important the concept of Community monitoring is in
an area as sensitive as that of health..
Finally, mention should be made of the Commission's proposal for a directive on
in vitro diagnostic medical devices2e, which completes the set o{ directives
covering all medical devices. This proprosal has received a favourable opinion
from the Ecorromic and Social Committee. It is currently undergoing the initial
consultation procedure at the Parliament and will be discussed by the Council's
Working Party on Economic Questions at the beginning of 1996.
Consumer protection - cosmetics
In July 1995, the Commission adopted the lSth Directive adapting to technical
progress the annexes of the basic directil'e on cosmetic products3o. These annexes
contain lists of substances which must not form part of the composition of
cosmetic products, substances $hich cosrmetic products can contain only subject
to restrictions or speiial conditions, and substances which cosmetic products may
contain ([JV-filters, preservatives and colouring agents).. Before being added to
one of these lists, the safety of the substilnce for human health is assessed by the
Scientific Commiftee on Cosmetology, which gives an opinion. The Commission
takes this opinion into account when preparing its draft proposal, which is
subsequently submitted to the Committe,e for Adaptation to Technical Progress.
In July 1995, the Commission adopted a 6th Directive on methods of analysis for
checking the composition of cosmetic products3r.
The Commission has adopted a directive establishing the criteria and conditions
under which a manufacturer may, for reasons of trade sectecy, apply not to
include one or more ingredients in the list of ingredients to be indicated on the
packaging of cosmetic products32. These rlriteria take into account the safety of the
consumer'as well as the justified commercial interests of the rnanufacturer.
OI C 280112 of 25.10.1995
Ol C27716 of 4.10.1994,C204122 of 9.8.1995. C307l14 of 18.11.1995
Ol C 172/2I of 7.7.1995, p. 2I
Commission Directive 95/34lEC of 10.07.1995, OJ L 161 of 18.07.1995, p. l9
Directiye 95/32lEC of 07.07.1995, OJ L 178, 2:8.07.1995,p.20
Directive 95/17lEC of 19.06.1995, OJ L 140, 23.06.1995, p. 26
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40. The Commission is currently finalising arn inventory of ingredients employed in
cosmetic products and a common nomenclature of these ingredients. These are
linked with the full labelling of ingredients in cosmetic products required after
January 1997. The idea is to enable the consumer to identify substances he should
avoid, e.g. because of personal allergy, vyhen buying a cosmetic product.
3.2.4 Ta<ation
Fiscal policy concerning the indirect taxation of goods has an effect on the price
of goods such as tobacco, alcoholic beverages and petrol. On 13 September 1995,
the Commission adopted a report on the approximation of excise duties33. In this
report the Commission clearly demonstrates how fiscal policy has to take into
account the general objectives of ther Treaty, including health protection
requirements as well as environmental questions.
Regarding the consumption of tobacco products, the report underlines that fiscal
measures represent a means of dissuasion. The revenue generated could Contribute
towards compensation for the "social cosl." of smoking, i.e. health care costs and
costs of scientific research. On alcohol anrl alcoholic beverages, from a social and
health policy point of view, taxation could be a means of discouraging excessive
consumption. It could contribute to reduce the problems associated with the abuse
of alcohol.
3.2.5 Jurisdiction on free movement of goods
42. Protecting public health is one of the k:gitimate objectives recognised by the
Treaty as justifying, where necessary and apprgpriate, measures that do not accord
with one of the basic principles of the intrernal market, i.e. the free movement of
goods. It is, in fact, often invoked by M,ember States to justify the adoption of
national regulations laying down technical specifications that affect the free
movement of goods within the single marrket.
43. In 1995, the Court of Justice delivered two judgments regarding the application
of the rules on free movemefrt in the light of health protection requirements.
In its judgment of 23.02.199534, the Court ruled that Council Directive
90/642|EEC of 27 November 1990 on the fixing of maximum levels for pesticide
residues in and on certain products of plant origin does not preclude national
legislation - in this instance, Italian regulations - from setting maximum
permissible levels for residues of Chlorprrcpham and Propham and providing for
procedures for checking compliance with those levels, on condition that such
provisions do not contravene Artieles 30 and 36 of the Treaty,
In its judgment of 28.03.199535, the Court held that a national practice - in this
instance, a British one - of prohibiting importation of narcotic drugs (diamorphine,
in this particular case) is covered by Artick: 30 of the Treaty. Moreover, an import
33 coM (95) 285 fin. of 13.09.1995
v Judgment of 23.02.1995, Joined Cases C-54l94 urd,C-74/94, [19951 ECR I - 3913r Judgment of 28.03.1995, Case C-3241g3, U9951 EICR I - 563
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ban would not be admissible under Article 36 if it were based on the need to
safeguard an undertaking's survival. On the other hand, such a ban may benefit
from the derogation provided for in Article 36 of the EEC Treaty if protection of'
the health and life of humans is at issue and this objective cannot be achieved as
effectively by measures less restrictive of intra-Community trade.
3.2.6 Free movement of persons
Recognition of diplomas in health professions
44. Health protection has always been an important consideration when it comes to
the mutual recognition of diplomas in the health professions (doctors, nurses,
midwives, pharmacists, dentists and veterinarians, in particular). The directives
concerning these diplomas are based on the free'movement articles of the Treaty,
49, 54 and 63, and aim to facilitate the free movement of professionals trained in
the Community in accordance with comparable standards of training. These
standards are being harmonised by drawing up common minimum requ_irenients.
In addition, advisory committees on the training of these professionals, set up to
support the directives, help to ensure comparably high skill levels by issuing
opinions and recommendation on training matters.
In so doing, they also contribute to the framing of health policies in the
Community.
45. Finally, the Committ6e of Senior Offrcials on Public Health, consisting of senior
oflicials from the Membeg States with direct responsibilities in the public health
field, has the task inter alia of gathering any useful information on atrangements
for providing medical and general care in the Member States and of issuing
opinions that help to guide the Commission's work as far as doctors, dentists,
nurses and midwives are concerned. For pharmacists and veterinaries, this task is
assured by two specific bodies. A proposal for a directive submitted by the
Commission to the European Parliament and the Council on 16 December 1994
is designed to enable this committee to assist the Commission by means of a
special committee procedure with a view to amending the lists of medical
specialisations and the length of the corresponding training courses set out in
Directive g3ll6tEF;C on facilitating the free movement of doctors. The
Commission has presented a modified proposal of the directive following the
opinion of Parliament36.
36 z7.rl.rggs, Joc c 28,01.02.t996
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3.2.7 Data protection
46. 1995 saw the final adoption of the European Parliament and Council directive on
the protection of individuals with regardi to the processing of personal data and on
the free movement of such data3?. The text establishes a framework of general
principles for the processing of data relating to individuals, and will apply
generally to all data processing covered by Community law, including that in the
health sector.
The needs of public health are recognised specifically in the text in a number of
.places, most notably in a recital which cites public health as an area where an
exemption to the prohibition on the processing of certain sensitive categories of
may be granted on grounds of important public interest.
The overall effect of the directive, r,vhich Member States have 3 years to
transpose into national law, will be to harmonise data protection legislation so that
personal data may move freely within the European Community on the basis of
a shared framework of rules. In the p'ublic health field this will facilitate data
processing which involves bringing together personal data from a number of
different Member States. Epidemiology and clinical trials are.two areas which are
likely to be particularly affected in this regard.
3.2.8 Education and training - KAROLUS
47. The KAROLUS Programme is a scheme for training officials from the Member
States through the exchange of nat:ional officials between Member State
administrations. Its purpose is to facilitate cooperation, and promote mutual
confidence, between national administra,tions, and to ensure a uniform and proper
application of Community legislation on the internal market. Among the sectors
covered by the exchange programme are some with a direct or indirect bearing
on health, such as medicinal products, foodstuffs, product safety, etc.
A gricultural and foods policy, fi sheies
The links between the quality of food and health are obvioirs. Therefore, the
different aspects ofagricultural, fisheries and foodstuffs policies are crucial areas
where health requirements need to be integrated into Community policy. It is
impossible to give a complete overview of all day-to-day activities of the
Commission in this field. In this section, major developments in 1995 concerning
the veterinary sector, pesticides, tobacco, wine and alcohol, foodstuffs, milk, and
the fisheries sector will be presented.
37 EP and Council Directive 95t46/CE of 24.10.1995, OJ L 281 of 23.11.1995
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3.3.1 Veterinary sector
49. A series of decisions were taken during 1995 by the Council and the Commission,
developing legislation on health and hygiene, concerning animals and products of
animal origin.
50. In fune, the Council adopted a directive amending Directive 64l433tEEC
concerning health conditions for the production and marketing of fresh meat3t. It
also adopted a series of decisions concerning tests for salmonella in certain
animals and animal products destined for Finland and Sweden3e.
The Commission adopted a number of proposals for presentation to the Council
including in particul ar a proposal on the marketing of meat productsao and a
proposal for a Council directive amending Directive 92/ll7/EEC concerning
measures for protection against certain zoonoses (diseases transmissible between
animals and man, such as rabies)at.
The Commission took many decisions to establish common health requirements
to be applied to the import of animals and products of animal origin from third
countries.
In addition, it was necessary to take a number of emergency safeguard measures
to limit imports of products from certain third countries where the health situation
was considered unsatisfactory. The import of fish from fapan was restricted after
an inspection revealed serious deficiencies in inspections and controls of products
to be exported to the European Communitynt. A Commission decision based on
a report from the Scientific Veterinary Commiffee authorised special heat
treatment to decontaminate bivalve molluscs in southern Spain containing low
levels of the PSP toxin. This decision applies only to Spain and is limited to a
particular species. Its purpose is ensure that this fype of product is safe for human
consumption. Following the outbreak of Ebola disease in Zaire, the Commission
banned the importation of apes originating in or coming from Zairen3. Both these
decisions form part of the measures to protect human and animal health in the
Community.
The veterinary and phytosanitary office continued its programme of inspections
within the Community and in third countries to monitor the application of and
compliance with Community health rules in the veterinary sector. Apart from the
fresh meat and meat products sector, checks were also initiated in the poultrymeat
and fish and fishery products sector. In addition, special visits were also made in
38 Directive g5/23lEC, OI L 243,I1.10.1995, p.7
3e Directives gsl4}g to 4l l/EC, OJ L 243,11.10.1995, pp. 21, 25, 2940 oJ c 269, 16.lo.l994r COM (95) 491 fin. of 23.10.1995
42 gsnrgrqc of 07.04.1995
43 Decisiors 95/lTltEcof 18.05.1995, OJL 112 of 19.05.1995, p. 30, and g5/3l3tE}of 24.07.1995,
OJ L 137, 08.08.1995, p. 23 i
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Member States and third countries in case of outbreaks of certain diseases to study
the epidemiology and check the health controls applied.
53. From 30 November to 1 December 1995, the Commission organised a major
scientific conference on growth promoliion in meat production. The conference
came to the conclusion that the accumurlation of experiences and published data
on the use of natural and sex hormones and related compounds (Zeranol and
Trenbolene) has shown no evidence of human health risk arising from their use,
when used under prescribed conditions. Further scrutiny is required to evaluate
effects on animal health. Substantial concerns about the potential risk for human
and animal health remain concerning the possible use of beta-2-antagonists as
glowth promoters. The conference consluded in addition that the illicit use of a
variety of growh promoters has become a serious problem. It saw therefore a
need for coordinating national control syrstems, to target surveillance systems more
effectively, and to enhance the efficacy of detection systems and methods.
3.3.2 Pesticide residues
In 1995, as part of the ongoing harmonisation of maximum levels of pesticide
residues in and on certain products of plant or animal origin, the Council adopted
three directives harmonising maximum residue levels for nine pesticide active
substances and amending existing maximum residue levels for some 20 pesticide
active substancess
3.3.3 Tobacco
55. The Community fund for tobacco research and information decided to fund a
number of projects, to commence in March 1996, both on informing the public
about the health effects of tobacco and on agricultr"rral research aimed at reducing
the harm caused by tobaccoas.
Council directives 95138/EC, OJ L 197,22.08.1tt95,p. L4 951391EC, OJ L 197,22.08.L995,p.29.
9516rlB1, OI L 292;07.12.1995, p. 27
cf. call for tenden published in OJ C 179/8 of 01.07.1994
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Tobacco and alcohol
Tobacco and alcohol abuse are among the major determinants for important
hedth scourges such as cancer and cardio-vascular diseases. In addition,
excessive consumption of alcohol is a major factor in accidents, be it on the
road, in the workplace or at home. Several areas of Community policy
address tobacco and alcohol issues.
In public health, there is a strong focus on the need to stop smoking and
moderate alcohol consumption in the context of activities to combat cancer.
Alcohol and tobacco were two major focuses of European Cancer Week in
October 1995.
Specific social policy actions aim at improving the situation of excluded and
disadvantaged groups in society. This may involve victims of severe alcohol
abuse.
Community agricultural policy covers tobacco, which is as an important
agricultural product of southern Member States. Ir has taken steps to
encourage the production of less harmful products, e.g. tobacco yielding low
levels of nicotine. The Community funds for tobacco research and
information will become operational in 1996 to support research and public
awareness campaigns in this area.
The production of alcoholic beverages also involves agricultural products
(grapes, hops, malt, etc.), and common market regulations exist for hops,
wine and spirits.
Fiscal policy,particularly concerning indirect taxation, has a major effect on
the pricing of tobacco and alcohol products and on choices made by
consumers. While indirect taxation levels have not been harmonised at the
EC level, there is an awareness that tax revenues from the sale of alcohol
and tobacco could provide important resources for preventive activities.
Alcohol and driving is a major concern for transport policy in the context of
road safety campaigns. :
See the relevant sections in this report for more details on policy
developments in these sectors in 1995.
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3.3.4 Foodstuffs
In the area of foodstuffs legislation, the Commission adopted a directive amending
Directive 90ll28lEEC relating to plastic rnaterials and articles intended to come
into contact with foodstuffs6.
The Commission also adopted the updated inventory of scientific cooperation
tasks on questions related to foodaT. Scientific cooperation provides a mechanism
allowing the Member States to assist the Commission with the scientific
examination of questions related to food. Many of the tasks undertaken relate to
subjects of direct relevance to public health.
The Scientific Committee for Food delivered a substantial number of opinions
relating to food safety covering additives, contaminants, materials and articles in
contact with foods and' adverse reactionsr to food and food ingredients. Their
opinions and reports will serve as the basiri for future legislative initiativ:es of the
Commission.
3.3.5 Milk promotion campaigns
58. Under the EC's school milk scheme, subsidlies are provided so that schoolchildren
can receive certain milk products at reduced prices. Although the prime objective
of this programme is to promote the consumption of milk products, its
contribution to achieving a balanced diet for schoolchildren has proved to be
equally important. In recent years, Member States have been encouraged to supply
suitable nutritiorral information on milk and milk products in schools, in order to
enhance the efficiency of the school milk scheme.
The range of milk products eligible for subsidy is suffrciently wide to comply
with the need for a varied and balanced dtiet in different circumstances. Within
this range, there is a clear trend towards those products with a reduced fat content.
In the school year 1988/89, whole milk products still accounted for some 77Yo of
the total quantity distributed ; for the 1994t"/95 period, this figure was reduced to
less than 65%.
3.3.6 Fisheries
There is a general consensus that the consumption of fish contributes to the
prevention of cardio-vascular diseases. Accordingly, the Commission has
continued its efforts to promote the consumption ol fisheries products and to
improve the quality of products sold to the public.
After the merging (in late 1993) of all the, structural financial tools in 
"irniqu"financial instrument for fisheries guidance (FFG), the Community action in
59.
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Directive 95l3lEC of 14.02.1995, OJ L 4t,23.02.t995, p. 44
Commission decision amending Decisio n94l652tE1)establishing the inventqry and distribution of
tasks to be undertaken within the framework of cooperation by Member States in the scientific
examination of questions related to food (9Sl492lE:"C of 15.11.1995)
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supporting these measures is canied out in the framework of the Structural Funds
reform, i.e. in integrated, coherent structural development plans covering the
period 1994-99, established in partnership between the Commission and Member'
Stut"., and implemented at local level. The new financial instrument has special
provisions for the promotion of consumption, including operations associated with
quality certification, promotion campaigns based on quality, and studies.
Moreover, all physical investment intended to improve conditions of hygiene or
human or animal health and to iinprove quality is eligible for aid in the sectors
of aquaculture, fish processing and marketing of fisheries products.
The total FIFG budget allocated to national plans for the period lgg4-gg is 2 67L
million ecus. Of this, 84 million is allocated to promotion and 859 million to
aquaculture, processing and marketing (this sum includes financing for measures
not directly lirtked to health requirements).
The FIFG also finances studies on an annual basis; in the period 1994-95, six
studies directly relating to quality or health matters were financed, with a
Community contribution in excess of 530 000 ecus.
3.4 Research and development
61. Research and development activities in the European Community take place in the
context of Framework Programmes for research and technological development
ETD) The 4th Framework Programmeas, which currently is the basis of RTD
activities, encompasses a number of specific RTD programmes which are either
health-related or include.projects with a health dimension.
3,4.T BIOMED
62. Health-related research and development activities take place mainly within the
Biomedicine and Health Programme (1994-1998 - BIOMED 2) within the 4th
RTD Framework Programmeo'. With a total budget of 336 million ecus, it covers
the following eight target areas:
Area l: Pharmaceuticals research;
Area 2: Research on biomedical technology and engineering;
Area 3: Brain research;
Area 4: Research on other diseases with a major socio-economic impact,
Area 5: Human genome research,
Area 6: Public health research, including health services research;
Area 7: Research on biomedical ethics;
#*"" 8: Ethical, legal and social aspects.
Decision 94/1f 10/EC of 26.04.1994, OJ L 126, 18.05.1994, p. 1, as amended by Decision
96l6I6lEC of 25.03.1996, OJ L 86, 04.04.1996, p. 69
Council decision 94l9L3tEC of 15.12.1994 adopting a specific programme of research and
technological development, including demonstration, in the field of biomedicine and health (1994-
1998), OJ L 361, 31.12.1994, p.40
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63. A first call for proposals was launched iin January 1995 with all thematic areas of
the work programme open to submission of research proposals. After scientific
and technical evaluation by independent experts, 307 out of 1709 proposals have
been selected for Community support with a financial contribution totalling 153.7
million ecus.
The selected proposals, notably in the fields of AIDS, cancer, occupational health
research and in particular public healtlh research, are expected to underpin the
public health initiatives in the context of Article 129 of the Treaty.
Likewise, the BIOMED 2 programme vrill be supporting demonstration projects
in order to prove the techno-economic viability of new medical practices (e.g. ex
vivo AIDS treatment restoration of movement of paraplegic patients by electrical
stimulation) and to disseminate these practices to users, industry, public entities
and other targeted interest groupings.
Vaccination is widely recognised as one of the most efficient tools of public
health policy showing evident cost-benelit advantages for all the target populations
involved.
With more than 5 million patients in western Europe, hepatitis C is the most
important chronic viral infection in thre region. Development of a vaccine for
hepatitis C is extremely complicated be,cause of the lack of knowledge regarding
immunological parameters, and can be a.ccomplished only through a collaborative
effort of multidisciplinary approaches involving several laboratories. The
BIOMED 2 programme is currently supporting a project for developing a vaccine
in which laboratories from five countries are participating.
it now appears feasible to develop canrler vaccines that induce cancer rejection
responses and stimulate the immune system to produce antibodies against cancer
cells. The BIOMED 2 programme ig supporting a transnational project involving
seven leading laboratories, the main aim of which is to identify antigens
recognised by T-lymphocytes on human tumours.
A number of research teams are devoting their efforts to develop vaccines against
chronic diseases by the development of highly immunogenic recombinant/peptide
vaccines and generation of new adjuvanrts.
The Task Force on Vaccines and Viral Diseases which has been established aims
at strengthening the European effort on vaccine development by fostering
partnership and cooperation in research and transposing the. latest scientific
advances. 
-
Research on the human genome - the genetic material contained in every cell in
the human body - aims at determining the structure of human DNA and the
identification and function of all the genes. The rationale for coordinated
European activities related to human genome research is based on its potential
contribution to the understanding of ttre processes underlying human disease,
hence to improve diagnostics, treatment and eventually disease prevention. This
objective is met through the improvement of research infrastructure, availability
64.
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ofresources and cooperation ofleading research groups in Europe in order to put
Europe on the map of the international human genome programme.
Particular progress was achieved through EUROGEM the European Gene
Mapping Project, which includes 23 laboratories. This network enabled European
researchers from all Member States, in particular those without national
programmes, to organise human genome research at a European level and to come
up with a European Genetic Map based on the CEPH reference families. At the
international level, the work on chromosomes l1 and 21 has been particularly
successful.
Thanks to a European initiative there are the so-called "Single Chromosome
Workshops" for exchange of information and data and reaching agreement on
nomenclature with regard to progress in the study of individual chromosomes. The
EC pays for the European organisers and participants; the U.S. (DOE and NtrI)
eventually agreed to follow the schenie and pay for the U.S. participants or
organisers. These workshops turned out to be extremely valuable in the
development of scientific collaboration and the establishment of research policies
in this field.
66. From a broader health perspective, a meeting was held in 1995 under the auspices
of the BIOMED prqgramme in DelftAIL on "Individual responsibility for health -
moral issues regarding lifestyle and a just distribution of medical resources",
bringing together experts from different Member States in the fields of public
health, sociology and ethics.
3.4.2 Telematics
Another area of RTD activities with an important health dimension is telematics.
The telematics applications programmeso includes specific activities on health care
telematics as well as for the disabled and the elderly among the 15 sectors in the
programme. It has an overall budget of 843 million ecus for 1994 to 1998. Health
care telematics has an indicative budget of 135 million ecus, while the sector
concerning the disabled and elderly has an indicative budget of 65 million ecus.
Most of the 42healthtelematics RTD projects initiated during the 3rd Framework
Programme came to an end in 1995. Seventy new projects with a total
Community contribution of 77 million ecus were negotiated in 1995 under the 4th
framework programme budget. As in other sectors of the telematics application
programme, stress is now put on actual validation of applications by "user groups"
in order to have effective up-take and deployment of results once the programme
has been completed.
Some of the fields covered by the programme are: development and inter-
operation of regional networks for a better integration and continuity of care,
cooperation of professionals in areas important for public health such as cancer,
Council Decision 94/801/EC of 23.11.1994, adopting a spccific programme of research and
technological development, including demonstration in the field of telematics applications of
common interest, OJ L 334 of 22.11.1994, p.l
67.
68.
22
cardio-vascular diseases and chronic illnesses. Inter-operability of telematics
services on a European scale is also covered, for example concerning emergencies.
In all cases, the objective is to increase the efficiency of the natural circulation of
information in the health sector, improving access while maintaining security and
stribt confidentiality. Management of feasibility studies in support of national
policies and of other Community policies is also a significant part of the acfivities.
3.4.3 G-7 Global Information Society Initiative
69. In February 1995, the G7 group of major industrialised nations launched a "Global
Information Society" initiative in Brussels. Among the I I projects included in this
initiative, the project on Global Healthcare Applications consists of six sub-
projects:
l. Towards a Global Public Health Network
2. Improving prevention, early detection; diagnosis and treatment of
cancer
3. Improving prevention, diagnosis and treatment of cardiovascular
diseases
4. A 24 hour multilingual telemedicine surveillance and emergency
service around the world
5. Enabling mechanisms for global health networks6. International harmonisation of the use of data cards in health care.
A global healthcare project meeting in Ottawa/Canada in November L995
launched a number of European feasibility str.rdies in preparation for these
initiatives.
3.4.4 Targeted socio-economic research
70. The programme on targeted socio-economic research is divided.into three main
areas: research into science and technology options in Europe, research on
education and training, and research on social integration and social exclusion in
Europesr. A number of projects funded under these headings - particularly in the
third area of action - are related to health.
3.4.5 Research on agriculture, fisheries and agro-industrial processing
71. The work programme of the FAIR (food and agro-industrial research) programme
for 1994-1998, which is the specific RTD programme for agriculture and
fisheries52, includes a number of references to health issues. The section on
agricultural environmental interaction also foresees health-related research, such
as minimlsing the passage of agrochemicals into the water table and thence to
5r Council decision g4lglstE? of 15.12.1994 adopting a specific progranrme of research and
technological development including demonstratioq in the field of targeted socio+conomic
research (1994-1998), OJ L 361 of 31.12.1994,p.77
s2 Council Decision g4l8OstEC of 23.11.1994 adopting a specific prognmme of research and
technological developmentand demonstration inthe field ofagriculture andfisheries...(1994-1998),
OJ L 334 of 22.11.1994, p.73.
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human drinking-water supply. A large part of the programme is dedicated to the
role of food in consumer nutrition and well-being.
In addition, four research projects in the :Freld of fisheries products upgrading,
which have connections to human health requirements, have been financed in
1995. The Community contribution to thesr: projects exceeded two million ecus.
3.4.6 Transport research
72. The Specific Programme for research and technological development in the field
of Transport within the 4th Framework Programmes3 continues to address safety
issues in all modes of transport. From an extensive list of tasks, the following
safety issues are particularly notewortlhy: 'the safety aspects of human
management' (rail), 'passenger survivabili.ty' (air), 'methodology of safety in
maritime operations', ild 'traffic management and vessel traflic system'
(waterborne) as well as 'improvements irn passive vehicle safety' and 'driver
behaviour' (road).
3.4,7 Environment and climate
73. The Environment and climate programme (1994-1998)ia has a total budget of 532
million ecus and covers four themes:
1. Research into the natural environment, environmental quality and global
cftrange,
2. Environmental technologies,
3. Space technologies applied to environmental monitoring and research,
4. Human dimensions of environmental change.
A first call for proposals was launched for themes 1,2 and 4 in fanuary 1995 and
after scientific and technical evaluation by independent experts, 315 out of 1601
proposals were selected for Community support with a Community financial
contribution totalling 216 million ecus. lli of 88 health-related proposals were
retained with a Community financial suppeft of 12 million ecus. These projects
complemented the 46 health-related projects financed in the preceding
ENVIRONMENT Programme which were still running in 1995.
Health-related research underpins the environmental health policies of the
Community and is consistent with the conclusions of the Intergovernmental
Conference on Chemical Safety (Stockholrn, April 1994) and the Declaration of
the Ministers of Health and the Environment (Helsinki, June 1994).
74. The main research priorities are to assess the impact of environmental factors (e.g.
ozone depletion, air quality pollutants) on the health status of populations
53 Council Decision g4/gl4/Ec of 15.12.1994 adop,ling a specific proganme for research and
technological development, including demonstration in the field of transport (1994 to 1998), OJ
L 361, 3I.12.1994, p. 56
s4 Council Decision g4lgIltEc of 15.12.1994 adopting a specific prograrnme of research and
technological development in field of environment and climate (1994-1998), OJ L 361 of
31.12.1994, p. I
24
(neurological, immunological, genotoxic, endocrine-disrupting effects, etc.) and
to improve risk management of chemical substances by developing more effrcent
testing methods (with an emphasis on reducing the number of animals required
for testing), by critically appraising the risk assessment process itself, by
developing new methodologies for hazard identification and exposure assessment
and by identifying vulnerable or susceptible groups in the population. The
research is implemented in close cooperation with international organisations in
the field. More than 200 European laboratories are currently involved.
3.4.8 Industrial and Material Technologies
75. Concerning the production technologies area, the Industrial and Material
Technoldgies Programme55 deals with the development of clean production
technologies emphasiang the efficent use of material and energy ressources, and
reduction or elimination of polluting wastes at their source. Reduction of
emissions is also a high priority within research related to transport means.
Specific attention is given to the health of the workforce employed in the
mandfacturing industries by developing safe and reliable production systems and
paying attention to human and organisational factors.
76. The research area on Materials and technologies for product innovation contributes
on a more long term scale to health, as it deals with basic research in materials
(e.g. surface behaviour, biocompability and strength of materials for implants),
development of special coatings (e.g. for targeted drug release and dental or
orthepeadic applications), research on medical devices and instruments for
diagnosis. The result will produce new applications and new methods (diagnosis
and treatment) for medicine.
77. A third area of the programme covers technologies for means of transport,
including all aspects of design, integration, production, efficency, environment,
safety and operation of the transport vehicle, be it an aircraft or any form of
surface vehicle. The aim of projects selected is to contribute to reduce the
environmental impact of production systems, products and means of transport and
to improve the safety of products and vehicles. This includes the reduction of
noise and pollutant emission from engines as well as primary vehicle safety
technologies - accident prevention - and secorrdary safety - the mitigation of
effects of accidents. Other projects aim to prevent contamination caused by the
exit of goods being transported in case of an accident.
3.4.g Standards, Measurements and Testing
78. The Standards, Measurements and Testing Programmesu has set up a specific
. management tool - the Dedicated Call - to allow targeted research on some
Council Decision 94l57llcE of 27.07.1994 adopting a specific programme for research and
technological development, including demonstratioU in the field of industrial and materials
technologies (1994-1998), OJ L 222 of 26.08.1994, p. 19
Council Decision 94/S03/CE of 23.11.1994 adopting a specific programme for research and
technological development, including demorstratioq in the field of standards, measurcmcnts and
testing (1994-1998), OJ L 334,22.12.1994, p. 47
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3.5
79.
specific subjects in support of European policies on standardisation. In 1995, 15
projects related to health, safety and en,vironmental topics have been selected,
amounting to some l3 million ecus.
Environmental policy, energl
In the framework of the Community Prog;ramme on Environment and Sustainable
DevelopmentsT, Community policy in the environmental field aims to integrate
environmental considerations into Community policies. Among the environmental
challenges and priorities of the programrne, the improvement of public health and
of health and safety (particularly the evaluration of industrial risks, nuclear security
and radiation protection) are explicitly mentioned.
The direct and indirect effects of the environment on health are becoming more
and more evident. A number of interrelated factors have already been identified
as influencing health:
- climate changes and global warming,
shrinking of the ozone layer,
- atmospheric pollution (concentration of ozone in the atmosphere, increased
concentration of sulphur and nitrogen oxides, particulate matter),
- soil pollution and acidification,
- surface and ground water pollution,
- exposure to man-made chemical agents and substances.
In the majority of cases, iegislation in these areas takes health considerations into
account.
3.5.1 Air pollution
80. A proposal for a European Parliament and, Council directive was adopted on the
approximation of the laws of the Membrlr States relating to the measures to be
taken against the emission of gaseous arnd particulate pollutants from internal
combustion engines to be installed in non-road mobile machinerys8. In addition,
a number of proposals were considered by the institutions in 1995: a directive on
the quality of ambient airse, a revision of the directive on air pollution from motor
vehicle emissionstr and a directive on diesel motor emissions in heavy vehicles5r.
Apart from legislation, reports on the imp)tementation of the ambient air directives
and on developments concerning ozone lvere published.
Fifth Programme - OJ C 138 - 17.05.1993
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82.
3.5.2 Radiation protection
81. In the framework of Chapter III (tlealth and Safety) of the Euratom Treaty the
revision of two important directives directly related lo health protection continued
in 1995.
First a revision of the Basic Safety Standards Directive (S0/836/EURATOM) for
the protection of workers and the public against the dangers arising from ionising
radiation was made, in order to take into account the latest scientific data. The
revision reinforces radiation protection, for example by reducing dose limits for
workers and the public, and by including in the scope of the directive exposure
to nafural sources of radiation at work. The Commission's proposal was accepted
by the Permanent Representatives on 2l December 1995 and was formally
adopted at the beginning of 1996.
Secondly, the revision of the Directive on the protection of persons unbergoing
medical examination or treatment involving ionising radiation
(84/466/EURATOIv0 continued. A formal opinion of the group of experts set up
under Article 3l of the Euratom Treaty was obtained on a Commission proposal
for revision of the directive. This proposal largely extends the existing directive
in order to take account of new techniques used in medicine and to clarify and
specify radiation protection aspects in this field.
Chapter III (Flealth and Safety) of the Euratom Treaty was applied to the nuclear
tests in French Polynesia: the Commission, in accordance with its responsibilities,
asked the French authoritieb for information on the radiation protection measures
taken to protect both workers at the nuclear site and the public, and visited the
aroa.
The Commission asked the French authorities to continue the monitoring of
environmental radioactivity in the area on a long-term basis and to communicate
the results to the Commission. It also asked an independent institute to make an
evaluation of the worst case scenario as regards geological accidents, which
confirmed the sound basis of the calculations made by the French authorities.
84. Besides these regulatory activities, the Commission is participating in research on
optimisation of radiation protection of the patient in diagnostic radiology.
Scientifically based guidance is established to fulfil clinical and technical
requirements for adequate diagnostic information obtained at reasonable dose to
the patient. The principle of safety culture is thus promoted both in the clinical
environment and on the manufacturer's side.
3.5.3 Chemical products
85. Concerning chentical products, the Commission put forward an amended proposal
for a Council Directive concernin g integrated pollution prevention and control62.
An amendrnent was also proposed concerning the draft directive on the marketing
62 coM (95) 88 fin. of 15.05.1995
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of biocidal products53, which provides for an authorization procedure for each
biocidal product put on the market, ba;sed on an evaluation of risks for human
health and the environment.
3.5.4 Civil protection
86. A process of reflection has been launched in the area of civil protection
concerning, on the one hand, emergency medicine in cases of disasters
(organisation at the moment of disaster, psychological follow-up) and, on the other
hand, the environmental impact of natural and technological disasters with a view
to reducing, or even avoiding, their serious consequences for human health and
the environment.
3.5.5 European Environment Agency
87. The European Environment Agency ba,sed in Copenhagen has recently_ become
operational. It has now ppblished a nnonograph "Environment & Health (1):
Overview and main European fssues" in the framework of the "Threats to Human
Health" project.
3.5.6 Energy policy
88. The relationship between energy and he,alth is mainly based on the direct effects
which production and the use of energy have on the environment, since pollution
directly influences individuals' health. At the end of 1995, the Commission
presented a White Paper on "An Energl' Policy for the European Community"s;
Among the common objectives outlined, the objective of the protection of the
environment will have a positive and direct impact on human health. Moreoveq
an integrated energy/environmental frarnLework will contribute to the achievement
of sustainable development.
The White Paper states that all problem,s related to spills, waste, noise, amenity
damage and atmospheric pollution produced by local emissions or the increased
emissions of CO, and other greenhouse gases must be dealt with increasingly at
the Community level, as their direct negative effects on public health are obvious.
This will particularly be done by making use of new technologies.
89. The Commission's proposals for two nel r programmes under discussion in 1995
- THERMIE II for the promotion and diissemination of new clean technologies6s
and SAVE II concerning a multi-annual programme for the promotion of energy
efliciency in the Communitytr - will, when adopted by the Council, greatly
contribute to alleviating global environmental problems.
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3.6 Tranryort
90. The importance of tr.ansport safety was reinforced by the Treaty on European
Union, which amended Article 75 to extend Community activities to "measures
to improve transport safety". All measures increasing transport safety contribute
to attaining a high level of health protection in the Community. In July 1995, the
Commission adopted a Communication on the Common Transport Policy: Action
Programme 1995-200067. Elaborating on the White Paper on the Future
Development of the Common Transport Policy6t, the Action programme maintains
safety as an integral component of the Common Transport Policy.
The Action Programme sets out in detail proposals and actions for the period
1995-1996 and identifies issues to be addressed in the period L997-2000 and
beyond. Safety is prominent in the list of these measures.
3.6.1 Ships
91. The loss of the "Estonia" with over 900 lives in the Baltic Sea in September 1994
highlighted the urgent need to improve the safety of roll-on/roll-off ferries. The
Commission prepared a proposal for a Council Regulation on the Safety
Management of Ro-Ro Passenger Vessels, which was adopted by Council on 8
December 19956e. The Regulation seeks mandatory application by I July 1996 of
the International Maritime Organisation's "International Safety Management Code"
(ISM Code) for regular ro-r€ passenger ferry services to and from ports of the
Community. In addition, it includes a provision for strict verification of
compliance by Member States. The development of a safety culture by means of
a Safety Management System under the ISM code can only have positive effects
on the safety of passengers and seafarers alike.
92. Although it is recognised that some 807o of accidents at sea can be attributed to
human factors, it remains the case that vessels and equipment on board vessels
may also be at fault. Conversely, safe and reliable equipment can often be the
very factor which prevents tragedy at sea. In June, the Commission adopted a
proposal for a Council Directive on Marine EquipmentTo which aims to submit an
extensive range of equipment to compliance with existing international testing
standards, or wJrere these do not exist, with future standards to be agreed within
the IMO. Compliance would have to be verified by notified bodies fulfilling
common quality criteria.
3.6.2 Transport of dangerous goods
93. During 1995, the European Parliament and Council discussed the Commission's
proposal for a Council Directive on the approximation of laws of the Member
States with regard to the transport of dangerous goods by rail. In December 1995,
67 coM (95) 302 fin. of 12.07.1995
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Council adopted its Common Position on the proposalTr. The potential health risks
associated with the transport of such goods by rail are significant, particularly
given the fact that these goods are often transported in quantity through urban'
areas. Moreover, the gradual opening of rail transport markets requires the
development of a framework of safety legislation to cover the transport of
dangerous goods by rail.
94. In October 1995, the Council adopted a Common Position on a long-standing
proposal for a Council Directive on the appointment and vocational qualification
of a safety advisor for the transport of darrgerous goods72. This proposal seeks to
-ensure that undertakings carrying out the transport of dangerous goods and related
activities appoint advisors to safeguard against risks to public health and safety,
property and the environmen! who would facilitate the carrying-out of the
undertaking's activities in the safest possible way.
3.6.3 Road transport
95. The Commission brought forward a proposal for a Council Directive on the
approximation of laws of the Member Startes relating to roadworthiness tests for
motor vehicles and their trailersT3. Its purpose includes the amendment of the basic
Directive 77/l43lEEC7a to include effectiv,e and regular testing of speed limitation
devices on certain heavy goods vehicles and buses, thereby contributing to general
road safety and to the health of the population. Opportunity was also taken to
consolidate the texts of this Directive, which guarantees that vehicles concerned
are sufliciently regulated and maintained to ensure road safety.
3.7 International cooperation, relations witlh third countries and international
organisations
96. Provisions on cooperation in the areas of h,ealth and health and safety atwork are
included in cooperation agreements between the EC and third countries.
97. The Euro-Mediterranean Conference in llarcelona identified health in its final
declaration as one of the areas of future r;ooperation in the region. In the work
programme adopted in Barcelona, the partners agreed to cooperate, in particulaq
on information and prevention activities, the development of public health
services, the training of personnel, and merdical assistance in the event of natural
di sastersT5.
In the trade relations between the European Community and third countries, health
protection is included in both bilateral and regional programmes, including the
transatlantic dialogue and activities in the firamework of the Community's Specific
Commitmi:nts to the General Agreement on Trade in Services.
98.
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99. In research cooperation with third countries, and international organisationsT6,
significant progress has been made on drug, diagnostic and vaccine research
aimed at providing the tools to combat the predominant disease problems of many.
developing countries. For studies of malaria, the STD-3 programme involved the
participation of over 80 teams in 33 different countries. Reflecting the importance
of this disease, malaria research, and in particular malaria vaccine studies, also
feature within the new INCO-DC programme. Discussions on possiblecooperation
with the United States on malaria vaccine development are underway.
3.7.I EC-USA cooperation
100. In the framework of the joint EC-USA Action Plan adopted ar rhe EC-USA
summit in Madrid on 9 December 1995, the two parties pledged to establish a
task force to develop and implement an effective global early warning system and
response network for communicable diseases. Furthermore, they have undertaken
to cooperate, bilaterally and within the framework of the WHO and other
international organisations as appropriate, on programmes on heatth-related
matters (AIDS and other communicable diseases, cancer, drug addiction), and to
identify specific areas for cooperation, especially in the research field.
101. The two parties have also pledged to explore the scope for an agreement for the
exchange of information on issues affecting health and safety at work, such as
occupational safety and health slandards, the development of regulations, high-
risk activities, carcinogenic substances at the workplace, toxicology, testing
programmes, education and information programmes, and the collection of
statistics and data. In addition, they are expected to explore the establishment of
improved mechanisms for the timely exchange of information related to the
general safety of products, including the withdrawal of products from the market.
I02. In the area of the environment - directly related to the protection of health - the
Community and the USA have pledged to strengthen the exchange of information
and repor'ting on global environmental issues such as climate change, biodiversity,
ozone layer depletion, persistent organic pollutants, desertification and erosion,
water quality and quantity, land-based sources of marine pollution, hazardous
wastes and contaminated soils, and forests. Furthermore, they have undertaken
to enhance their bilateral dialogue on regulatory cooperation, including:
- extending cooperation on chemical issues;
- continuing work on biotechnology issues, such as the mutual acceptance
of data for assessment and the release of genetically modified organisms;
- enhancing work on air pollution:
Coun"ii Decision 94/807/CE of 23.11.1994 adopting a specific programme of research and
technological development, including demonstration in the field of cooperation with third countries
and international organisations, OJ L 334, 22.12.1994, p. 109
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3.7.2 Cooperation with Central Europe and the Community of Independent States -
PHARE/Tacis
103. Phare has concentrated its support on kr:y areas of reform along the lines of the
Health Strategy Paper revised in 1994 (health financing, reorganisation of health
' 
services wittripecial emphasis on primary health care, pharmaceuticals policy,
human resources management and training, and prwentive measures), areas which
were already mentioned in the first strategy paper. In programme design and
adaptation of ongoing programmes, wlhile pursuing the specific objectives of
health sector reform, Phare has paid special affention to the wider objective of
integrating countries with association agreements. A total amount of over 130
million ecus was committed to health sector restructuring in the period 1991-1995.
During 1995, implementation of the ong,oing programmes in all the Phare-eligible
CEECs, except Slovenia" continued, while new programmes were approved for
four other CEECs.
With regard to Tacis, in 1995 a start wasi made on work under the 4.5 million ecu
programme for Russia approved in l!)94 involving support for health sector
reform in 4 pilot areas.
In 1995, new programmes with a healtltr component were developed for Russia
and Moldova.
104. a) Ongoing Phare/Tacis activities in 1995
In Albania, ongoing activities are taking; place under two programmes (1993 and
1994) and concern: i) primary health ciare development through strategy design
and re-training of 500 general practitic,ners and 1800 nurses; ii) reform of the
hospital system through twinning with EC hospitals and training to streamline
management practices, the creation ol' a maintenance service for biomedical
equipment, improving the diagnostic and follow-up capacity of hospital
laboratories, and restructuring the emergency services; iii) technical assistance
with setting up a legal framework for the health sector; iv) restructtrring of the
pharmaceuticals sector lnvolving the creation of an infusion fluid production line
and assistance in establishing a pharmaceuticals inspectorate; v) preventive
medicine, with the restructuring of the nr:twork of public health laboratories. Most
of the work under the 1993 programme was completed during 1995.
In Bulgaria, activities comprise two programmes ltSiSZ and 1993) and concern:
i) health financing, including assessment of costs for medical procedures, and
health insurance issues; ii) training in devising a training policy for medical and
para-medical staff, training of medical personnel and officials involved in the
decentralisation process, creating a faculty of nursing in the University of Sofia,
improvint' training in general medicine t[post-graduate and continuing education);
iii) pharmaceuticals policy involving inter alia harmonisation of national
legislation and practice with those found in the EC; iv) a framework for private
practice aimed at the development of a rvell-balanced mixed publiciprivate health
care system; vi) health and safety at work with collaboration between the Ministry
of Health and the Ministry of Labour. Most of the activities under the 1992
programme were completed in 1995.
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In Hungary, the 1993 programme aims at: i) the development of a modern
primary health care system covering dl aspects (legislation, policy and
implementation strategy, training, operational research, communication strategy,
etc.), combined with an innovation fund providing grants for public or private
PHC initiatives; ii) harmonisation with EC legislation and best EC practices as
regards health and safety at work and the training of health professionals. Work
is still continuing
In Romani4 some work on health financing reform was continued under the
health component of the social programrie.
In FYROlvt, assistance in preparing a pharmaceuticals policy was continued as
part of a humanitarian aid package which initially included the supply of
pharmaceuticals.
Existing programmes were completed in the CzechRepublic (health care financing
and health insurance administration, health information system) and Slqvakia
(devising methods for assessing and managing medical equipment, designing a
strategy for primary health care development and for health care management
including coverage of the immediate continuing education needs of existing staff)
as well as in the Baltic States.
In Russi4 the activities initiated in 1995 under the 1994 programme covered the
development of primary health care @HC) services in the form of "pilot oblasts",
the modernisation of hospital practices and management as well as a
demonstration project on maternal and child health in one pilot area.
105. b)New Phare/Tacis programmes in 1995
New Phare programmes were prepared for Slovakia agrd the three Baltic States,
partly as a continuation of previoirs support:
In Slovakia, the programme focuses on 4 areas: i) health financing reform
addressing issues such as pricing and payment systems, accountahcy and
information flow between care providers and financing bodies, resource allocation
criteria and the development of investment strategies for health care infrastructures
and equipment; ii) preparation of a framework for private practice with a view
to developing a well-balanced mixed public/private health care system; iii)
implementation of a PHC strategy; iv) implementation of a health management
strategy.
In the Baltic States the focus remains mainly on previous priority areas: health
care finanCing reform in all 3 countries; in Latvia and Lithuania support is also
given to human resources and training, primary health care development and
pharmaceuticals policy, while in Estonia support is also provided for information
systems.
In all these new programmes, it is planned to devise and implement a
communication strategy on health reform directed at health professionals and the
general public.
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106. In addition to these national programimes, a l0 million ecu multi-country
programme initiated by the Commission,, named CONSENSUS, was launched in
1995 to provide policy advice and support for social protection reform in Phare-
eligible countries. Inter-Institutional Reficrm Committees have been set up in the
CEECs and a Programme Advisory Borard, composed of the 15 EC Members
States and all the Phare-eligible CEElCs, advises on programme policy and
selection of project proposals. The scope of this programme includes health care
financing issues and health care delivery. It is being implemented in close
collaboration with DGV
With regard to Tacis, in 1995 new programmes with a health component were
drawn up for Russia and Moldova:
Russia: two actions were initiated
' * A 2.6 million ecu programme, aimed at the coherent implementation of social
and health care reforms, was finalised for the Republic of Karelia. It deals with
the management of social protection by the lvlinistry of Social Wllfare in
cooperation with other ministries such asrthe Ministry of Labour and the Mnistry
of Health, as well as management of the lhealth care systems, which remains under
the responsibility of the Ministry of Health but is in practice exercised. by local
government agencies.
* 500 000 ecus were made available for policy advice for the Russian Govern-
ment concerning both the demand and the supply side of pharmaceuticals, with
a view to improving their distribution and production.
Moldova: In the framework of the programme "Technical Assistance on Human
Resource Development" a sum of 500 1000 ecus was approved to cover primary
health care development and health care management.
lO7. Furthermore, health considerations pla,yed an important role in the ongoing
contacts and cooperation activities with Central and Eastern European countries,
aimed in particular at evaluating the siluation and specific needs as well as the
scope for cooperation in the social and health fields, including the possibility of
opening Community programmes in the:held of health to the participation of these
countries.
108. The Link Inter-European NGOs (LIE.I.[) programme, initiated in 1994 and
covering both Phare and Tacis countries, is aimed at stimulating activities of
NGOs in favour of deprived communities. In the health field, the actions can
cover:
assistance to women having limiited access to health and social services;
suftainable health and social support for the most disadvantaged t^rget
groups, such as the disabled, victims of addiction, people with HIV/AIDS,
street children, the elderly, etc.
Health projectS for over 1 million ecus have been approved in nulgaria, Hungary,
Lithuania, Poland and Slovakia. Amo:ng these projects the following deserve
mention:
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- establishment of a centre providing palliative home care in the region of
Sofia.(for persons suffering from incurable illnesses such as cancer and
AIDS);
- professional training for young people with drug problems and criminal
records;
- improving women's health in Slovakia through the development of
sustainable reproductive health care services;
- rehabilitation of children with cerebral palsy;
- AIDS centre: assistance, education, information and documentation;
- 
' model for community-based health care for vulnerable older people
(mental illness and dementia).
Coordination and coherence is maintained between these activities and the
European Community programmes in public health such as cancer, AIDS, drug
dependence and health promotion.
3.7.3 Cooperation with international organisations
109. The European Community continued to follow health-related activities in the
Council of Europe and was represented on several relevant committees and
groups. In 1995, the major items under consideration related to blood (blood
ruf.ry and self-sufficiency, including the proposed revision of the technical
protocol to Agreement No. 26), the proposed Bioethics Convention and a number
of other subjects, including organ transplantation, the organisation of health care
services for persons in custody, recommendations on nursing research, health
information in hospitals, health problems of single-parent families, and health,
dignity and social exclusion.
l l0. Cooperation with the World Health Organisation (including the European Region
and the International Agency for Research on Cancer) has continued at a
satisfactory level. The WHO Directsr General, Dr Nakajima, visited the
Commission in June 1995.
The Commission participated in the World Health Assembly, the Executive Board
of WHO and thqEuropean Regional Committee meetings. The meeting of the
Regional Committee in ferusalem (September 1995) recognised the importance of
plaiing statements from the European Commission on its activities in the health
field high on its agenda.
3.7 .4 Cooperation with ACP countries in the health field
lll. 1995 saw the revision of the Fourth I-lrn6 Convention, which since 1990 has
governed Cooperation between the European Community and African, Caribbean
and Pacific (ACP) countries. The new agreement, signed on Mauritius on 4
November 1995, does not represent a new departure but strengthens and partly
recasts a convention that will remain in force until the year 2000,
In this connection, a start has been made on work preceding the negotiations
leading to the adoption of the indicative programmes. In 1995, this work mainly
involved an examination of cooperation strategies at region and country level.
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In the course of this examination, questions of health and AIDS were given
greater consideration than in the past. Thusi, even though it is of course impossible
to anticipate the results of the negotiatio,ns on the indicative programmes, the
signs are that funding for the health sector will continue to rise when the 8th
Lomd financial protocol is implemented.
ll2. The work carried out over the past few years in the fields of health and AIDS
continued in 1995. Apart from the monitoring of the development projects funded
under the 7th EDF which are now undrgrway and assistance given under the
structural adjustment facility, several new and important financing decisions were
taken. Particular mention should be made of those relating to:
* Mozambique, where 22 million eous were allocated to a programme for
improving the health system in runal areas
Kenya, for a "family health" programme (drawn up jointly with the ODA
in the UK) to which the Commission contributed 14.8 million e-cus.
A number of other operations were decided upon, Burkina Faso (support for
reform of the pharmaceutical sector, 1.6 million ecus) and Central Africa (support
to improve primary health care, 1.8 million ecus).deserving particular mention.
113. As regards STDs/HIV/AIDS, the Commission continued to implement its main
strategies by focusing on prevention, the strengthening of health services,
consideration of the socio-economic impact of the epidemic, and scientific
training.
Major programmes were adopted in 1995, relating in particular to the
incorporation of the STD/FIIV/AIDS strategy into health systems (including a 5
million ecu project in Mozambique and a 4 million ecu scheme in Tanzania). As
for operational research, 1995 saw the r:ompletion of an important project at
Mwanza in Tanzania showing how treating STDs reduces HIV transmission.
Finally, at regional level, a number of HI'V/AIDS awareness campaigns aimed at
the general public were organised via the mass media. These included radio
campaigns in some Asian countries as well as television campaigns (advertising
spots during the African Nations Cup).
Il4. Meetings of technicians and national expe,rts from ACP countries were organised
in Brussels to discuss "decentralisation o{'health systems".
The first of these, held in November 1995 and dealing with the situation in
French-speaking countries, broulht together over 30 participants from west and
central Africa.
Its purpose was to review the situation in these countries and to examine the
constraints, limits and consequences associated with the decentralisation process,
which is an important factor in the healthr system reforms now taking place.
1I5. The process of improving coordination with the Member States, the main features
of which were decided upon by the CounLcil in 1994, continued in 1995.
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Activities in this area included further meetings of the expert groups "health and
development" and 'STD/AIDS" as well as efforts to progressively improve
operational coordination'in the countries themselves.
Action was also taken to extend joint consultation on policies and strategies and
to improve operational coordination with, in particular, USAID and the World
Bank.
116. 1995 also saw the convening of the second meeting of health ministers of
countries in the franc area and associated countries on medicines policy, which
was held in Brussels in April.
This meeting is part of a process initiated by the Ivory Coast with the support of
the EC following the devaluation of the CFA franc in 1994, the aim being to
promote joint discussion and action with regard to policies on medicines.
The meeting adopted an action plan with the following objectives:
* setting up an information network on medicines and their prices in Africa;
* strengthening mechanisms for the quality control of medicines;
* speeding up the introduction of generic medicines in the private sector;
* harmonising legislation;
improving the way in which medicines are prescribed and dispensed.
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AIDS
L HIV/AIDS today poses a major scientific and social challenge.
Addressing the problem of HIV/AIDS r:alls for a multi-disciplinary response
that combinOs the best of biologiorl and medical research, effective
interventions to deal with the socio-reconomic causes and consequences,
particularly for the most disadvantaged groups and the poorest countries,
actions to monitor and reduce the spread of HIV infection, notably by
education and information, and provision of support for those living with
HIV/AIDS and their families.
The European Community has played and continues to play a major part in
the international HIV/AIDS effort. The actions implemented by the European
Commission range across the whole span of the responsibilities of the
, Community, but focus mainly on thre following three areas of activity:
research, development assistance, and public health.
2. HIV/AIDS prevention in Europe : the JEuropean Community's priorities
By 3l December 1995, a cumulative total of l5g 343 AIDS cases had beeh
reported in the fifteen countries of the European Community since the
epidemic began. Cases tend to be geographically clustered with a gradient
of decreasing incidencb rates from the south-western to the north-eastern
countries. Against the background of rapid increase of AIDS cases, a
consensus has emerged that the Comm.unity needs to play a significant role
in the response to the epidemic.
Since 1988 the European Community has tackled the issue of AIDS in the
framework of public health. A i'Europe against AIDS" programme was set
up in June 1991. Under the Trealp on European Union of 1993, the
European Community was given a new competence in public health, namely
that Community action should be clirected towards "the prevention of
diseases", in particular the major health scourges. Up to 1995 about 360
transnational projects involving NGO's have been funded for approximately
40 million ecus.
A new draft programme of Community action on the prevention of AIDS
and certain other communicable disr:ases for the years 1996-2000 was
discussed by the institutions in 1995, with a view of adoption in 199677.
This new programme, with a budget of'49.6 million ecus, will have four key
priorities:
77 The progamme was adopted on 29.03.1996 - Decision 645lg6lEc - cf. OJ L 95 of 16.04.1996
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- surveillance and control of AIDS and certain other communicable
diseases,
- combatting transmission of HIV,
- information, education and training,
- support for persons with HIV/AIDS and combatting discrimination.
The programme is implemented through:
- support for Community wide projects,
- support for innovative projects,
support for NGOs' activities, including the establishment of inter-
country links,
- setting up of networks.
This programme is open to the participation of countries in association
agreements with the European Community and promotes cooperation with
international organisations active in this field.
The HIV/AIDS programme for developing countries
The Commission began its work concerning HIV/AIDS in developing
countries back in 1987 and has endeavoured from the start to ensure that its
activities are closely coordinated with the WHO's special programme dating
from the same year.
Over the years, the programmes have evolved from preventive measures
taken in an emergency situation towards strategies and policies which deal
with HIV/AIDS as a structural problem requiring a long-term strategy and a
multisectoral response
This response must first come from the health and welfare sectors, which in
many countries are undergoing reforms aimed at greater efficiency in the
provision of services while at the same time having to cope with a
significant increase in the demand for HIV/AIDS-related care. However, the
consequences of the epidemic and the responses called for go well beyond
the health sector, involving as they do respect for human rights, non-
discrimination towards persons with HIV/AIDS, and the social and family
structures affected by the epidemic.
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4.
It is against this background that the Commission has, in close collaboration
with the EC Member States, endeavoured to develop an appropriate policy
and strategy for dealing with the HIVTAIDS problem. If Community support
and bilateral aid are taken together, the EC is the largest contributor to the
fight against HMAIDS in developing countries. Efforts to improve
coordination led in 1994 to the submiission of a Commission communication
to the Council and the European Parliament on policies and strategies to deal
with HIV/AIDS. On the basis of this communication, a Council resolution
was adopted in 1994 followed by a Parliament resolution in 1995. Four
action priorities were identified:
- controlling the spread of thre epidemic by means of preventive
measures;
- strengthening the health sector to enable it to cope with the additional
burden resulting from the epidemic;
- helping countries to pay more attention to the social and economic
, consequences of AIDS;
- developing scientific knowledge and skills.
Close coordination is taking place both with the Member States and with the
UN AIDS programme as well as with other international organisations
working in this field.
In overall terms, when all countries and all financial resources are included
(excluding co-funding by NGOs and research), Community spending in this
area since Iuly 1987 amounts to over 160 million ecus.
The Biomedical and Health Research Programme
The European Commission's activities in the area of research in biomedicine
and health dates back to the launching of the First Medical and Health
Research Programme in 1978. It hars ever since steadily grown both in its
research ambitions as well as in its budget available for supporting European
research in areas of high priority.
Medical research at the EC level aims at: pooling of data, avoiding
duplication of effort, standardization of methods and reagents, better
selection of cohorts for clinical trials, bringing together complementary skills
in multi-faceted projects, improved training possibilities for young
researchers in specialized fields, better utilisation of results in the public
health sector, creating better access to research results for all parts of
Europe, establishment of European shared facilities for animal
experimentation in order to reduce the overall number of animals used in
experimentation and increase cost-efllectiveness.
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Ever since 1983, only two years after the first case of AIDS was diagnosed,
the European Commission has taken on an active role in the fight against the
AIDS epidem-ic. Funding of research on AIDS began in 1987 under the
Fourth Medical and Health Research Programme. The ambitions of the
programme as well as the budget available have been significantly increased
over the years. At presen! the programme is supporting a total of 51
projects including over 600 research teams with a budget of 32 million ecus
under the BIOMED I and BIOMED 2 research work on AIDS - figures
which will grow shortly as the Commission has made its selection for
funding among the recently submitted project proposals.
The projects are all closely related to the three main priorities of the
programme:
- development of safe and effective vaccines against HIV infection
development of therapeutic agents suppressing progression of the
disease in infected individuals
- research on the epidemiology of the virus in Europe
5. The International Scientific Collaboration Programme - Health Research for
Development
This programme, concerning research collaboration between European
groups and scientists in developing countries, contains an important
component on health research in which some activity on HIV takes place as
well.
16 joint research projects have been funded with partners in Africa and Asia
with a budget over 5 million ecus.
The programme invests in research on the epidemiology of HIV in
developing countries, mechanisms of vertical HIV transmission, longitudinal
studies of HIV infection profiles, biology and epidemiology of HIVIIBC co-
infection, role of other STDs in the epidemiology of HIV, international
research against STDs and HIV with particular regard to evaluation of
upgraded STD patient and clinical services.
See the relevant sections of this report for further information on 1995
activities in these areas of policy.
3.7.5 Cooperation with South and South East Asia, Latin America
lI7. In Asian countries, a number of important health programmes have been launched.
They were concentrated, on the one hand on an extensive malaria control
programme (Cambodia" Laos and Vietnam, 29 N{ECU) and on women's health and
safe motherhood (?hilippines, 17 MECU) on the other. Two smaller projects
concerned primary health care @angladesh, 9.95 MECU) and reproductive health
Q.{epal, 0.9 MECU).
4l
t 18. Support to the health sector is increasin grapidly with Latin America. In 1995, the
treatttr sector represented 6 % of the total amount of all the on-going projects from
this budget line, and there will be a significan{ increase in the future. Among the'
financial proposals approved in 1995, 30 % constituted support to. the health
sector. This implies that in 1996 the share will raise to9 o/o of all projects under
implementation. In addition, the majority of rural development programmes
inClude components related to healthr, such as water and sanitation and
construction of health centres, etc.
In 1995, the total amount disbursed to the health sector was 54,5 MECU, the
support being mainly concentrated to Central America (77 MECU to health
projects in El Salvador and 2l MECU to regional projects); Among the regional
-projects it is worth mentioning the Project "Salud materno-infantilu (16,0 MECU),
which is addressing specific problems rdated to reproductive health.
3.7.6 Fight against drugs
119. The Phare Multi-country Drugs Programme covers all countries of Central and
Eastern Europe (ll countries) and has been operational since 1993. Health
education, training and other preventi're measures, as well as treatment and
rehabilitation components represent a significant part of the prpgramme. It is a
multidisciplinary programme promoting cooperation among the Phare partner
countries in the fields of drug demand arnd supply reduction and the development
of a global approach towards the drugs phenomenon. The programme has helped
to raise offrcial awareness of the problern of drug use and to initiate the creation
of structures at national level to coordinate actions and bring together all actors
in the field.
Regional training activities have been rrrganised on topics such as schools, the
f'amily, the community and the media.
A second regional report on drug denrand reduction was prepared in 1995; it
shows both an increase in drug use and the development of local awareness and
facilities to deal with the problem. The report was discussed at a joint CEEC-EC
seminar in Luxernbourg in September l9)95, thus enhancing the cooperation which
was established in 1994 benveen this programme and the drug-related activities
carried out inside the Community.
Approximately 2 million ecus have been spent so far on this activity.
120. In the context of North-South activities, particular emphasis is pl.aced on the fight
against drugs and drug dependence. A total of 8.7 million ecus was utilised to
support actions to reduce drug su;rplies (trafficking controls, alternative
developments) and demand (prevention, treatment and rehabilitation).
3.7.7 Humanitarian aid
I2l. TheEuropean Community Humanitarian Office, ECHO, which has been operating
since 1992, plans, implements, finances, monitors and evaluates operations and
decisions 'concerning humanitarian arid. When health systems are clearly
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inadequate, preventive humanitarian measures may be taken to stop epidemics and
assist the population. Gven the limited resources available to ECHO, this type of
assistance is only provided in a serious situation.
l2Z. In 1995, man-made disasters accounted for 96Yo of ECHO's worh the remaining
4o/o relattngto epidemics-or natural disasters and their prevention. During the year,
ECHO followed the same approach as in 1994 in respect of its emergency health
protection measures:
- supply of medicines and medical equipment (the most important health
measure taken by the Oflice);
- vaccination campaigns;
- checking the quality of distributed foodstuffs;
- infrastructure work to improve the general standard of health, and training
of local medical Personnel.
123. The main emergency operations undertaken by ECHO in 1995 in the health field
were predominantly directed at the Great Lakes Region (Rwanda, Burundi). But
they also concerned the vaccination of, and support for, cholera victims in Liberia,
Guinea, Nicaragua and Peru. In addition, a major contribution (15 million ecu)
mainly in form of medicines and food, was made to a global campaign launched
by UMCEF aimed at combatting a renewed outbreak of diphtheria and
tuberculosis iir Russia, the Community of Independent States and the Baltic States.
3.7.8 Environment and health
124. The Community plays an important international role also in the area of
environment and health. It is participating in the activities of the UNCED
Commission on Sustainable Development and is represented on the European
Committee for Environment and Health (ECEFD, which is responsible for the
follow-up of the Second European Conference on Environment and Health held
in Helsinki in 1994. The next meeting is due to take place in London in 1999.
3.8 Integration of health requirentents in other Community policies
3.8.1 Statistics
lZ5. A condition for Community action in any field is the existence of reliable,
accurate and accessible data. Under the Framework programme for priority actions
in the field of statistical information 1993-19977t and with close involvement of
the Statistical Programme CommitteeTe, sectoral programmes for social policy
statistics are being further developed.
126. In close cooperation with the Member States, Eurostat (the Statistical Office of
the Europeun Community) is collecting, analysing and disseminating statistical
information on a wide range of items related to social and economic aspects, such
78 Council Decision 93l464lEEC, 22.07.1993, OI L 219,28.08.1993, p.l
7e Esbblished by Council Decision 94l382lEEC, Euratonr, OJ L 181,28.06.1989, p.47
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as demography, environment, poverty and social exclusion, social protection,
public health, and health and safety at work. A number of publications containing
inter alia statistical information on hearlth and safety were published in 1995
@urostat Yearboolg Social Portrait of Europe, Women and Men in the EC,
Disabled persons: Statistical data - second edition).
127. Data on accidents at work @SAW: European Statistics on Accidents at Work) are
collected on a regular basis and a database has been designed. A task force has
been set up to discuss methodological issues such as coverage and under-
reporting, as well as changes to certain r:lassification systems. A pilot project on
developing comparable studies on occupational diseases (EODS: European
Occupational Diseases Statistics) for 3l substances and diseases has been launched
and a prototype database has been created. A technical sub-committee to develop
new classification systems for factors on biological, physical and chemical
exposure has been established. The basic variables for which data are being
collected will provide the first reliable Community-wide statistics on workin!
conditions.
128. On the collection at Community level of data on home and leisure accidents(EHLASS), Eurostat has provided assistance in the preparation of summary
reports and the revision of methodologies.
L29. In 1995, the second wave of the European Community household panel took
place. The first wave (1994) data of this multidimensional panel survey, which
provide information on a wide range of'socio-economic issues including health
and medical consumption, are currently being analyzed.
130. These health-related activities will t,e coordinated with the forthcoming
programme on health monitoringto. In close cooperation with other Commission
services and with international organisations active in the field of health statistics(WHO, OECD), existing projects on 'causes of death statistics', 'health interview
surveys' and 'health resources' will be fi.rrther improved in view of this coming
programme.
3.8.2 Youth and education
131. The SOCRATES Community action programme (1995-lggg) is designed to
oontribute to the development of quality education and training.
Chapter I, relating to higher education (ERASMUS), provides for measures to
promote student and teacher mobility, the setting up of thematic networks, and the
development of curricula for various subject areas. The latter include medical
sciences Such as medicine, psychiatry, dentistry, public health, pharmacology,
medical technologies, etc.
chapter II, covering school education (coMENrus), has a section on
"partnerships between schools" (Actionr 1) that is aimed at encouraging the
creation of partnerships between several schools in different Member States which
E0 COM (95) 4:19 fin. of 16.10.1995 - see above. I,ubtic health
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will cooperate on European education projects (EEP). The latter aim to develop
subjects of Furopean interest (culturage heritage, the environmen! science and
technology, etc.). One such subject could be health promotion in schools.
132. The Youth for Europe programme gives financial support to projects and
exchanges organised by youth initiatives and organisations. Specific actions
support periods of voluntary service and exchanges outside the European
Community, including CEECs, the NIS, Latin America and the Mediterranean
region.
While health is not a specific programme target, a'number of projects receiving
financial assistance in 1995 had a health dimension, relating for example to drug
prevention and abuse, alcohol, AIDS prevention and the provision of care and
support for people with HIV/AIDS, health education and young people with
disabilities. One project relates to health in the context of basic youth rights to be
accorded to all young peopletr.
3.8.3 Information activities
133. The Citizens First campaign, designed to help to bring Furope closer to the
individual citizen, ryas adopted by the Commission in October 1995. In the run
up to the Intergovernmental Conference, the Commission intends this campaign
to demonstrate the benefits of the internal market to citizens. This general
objective will be developed in the context of ten specific themes. When the
information campaign on one of the themes is launched, the Commission will
publish both a guide and a factsheet. Two of the themes have a particular
relevance for health: health provisions in the single market, and health and safety
at the workplace.
3.8.4 Regional policy
134. As outlined in th'e 1994 report, investments in education and health in objective
I regions are now included in the scope of the European Regional Development
Fund @RDF). While it is too early to provide any detailed assessment of the
' effect on health of this expenditure (the Commission does not yet have a complete
overview of all projects funded according to target area), it is clear that, in
qualitative teims, significant health benefits are expected from improvements in
the overall environment and infrastructure of the regions concerned.
3.8.5 Drugs
135. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in
Lisbon became operational in the first half of 1995. As the centre's physical
infrastructure was not in place before mid-year, activities concentrated on gearing
up for the tasks assigned to the Centre and on launching work in the main priority
areas defined by the Centre's 1995-97 work plan.
8r 
cf. Youth for Europe statistics 1995, DG )OOI, Doc. YfE-D95406E
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136. The Centre has concentrated on the following objectives: L Definition of a set of
principles for information collection, 2. ldentification of key indicators and core
iatq -f. Identification of mechanismsi for providing appropriately analyzed
information, 4. Establishment of effecti've working relationships with competent
international institutions and bodies, 5. Establishment of working relationships
with the main research groups and centres in the Member States, and, finally, 6.
Establishment of ,.rorrn.ndations for the Management Board concerning action
to be taken in these fields. The completion of this work is a precondition for
preparing the Annual Report on the Dnrgs Sitgation in Europe.
137. Taking into account these objectives, the centre focused its activities in 1995 on
reviewing the diverse studies and initiatives undertaken by the Community prior
to its cieation. These covered three main areas: demand reduction and
epidemiology, implementation and coordination of the REITOX network and the
national foJal-points, and a restructuring of relations with the Centre's institutional
and scientific iartners. The work of the REITOX network was reviewed in 1995,
with a view io improving this successful cooperation between Membbr States
concerning drugs questions.
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4. Conclusions
138. This second annual report on the integration of health requirements in Community
policies shows clearly how almost all main policy areas in the Community have
repercussions on health and take health considerations into account.
139. It shows that a number of subjects are being addressed by several different policy
areas: work on tobacco, for example, takes place in the context of the preventive
activities of the Europe against cancer programme. In addition, agricultural policy
deals with the growth of tobacco plants; research is being conducted on less
harmful tobacco varieties and indirect taxation of tobacco products is being
considered within the context of ta<ation policy. A similar situation exists
concerning drugs, which are a topic for action in public health (with a programme
proposal being discussed by Council), for cooperation in internal and justice
affairs, or in North-South work. Drugs-related projects are also funded by
programmes directed at the fight against social exclusion and by the Youth for
Europe programme. The specific programmes targeted at Central and Eastern
Europe all include a health dimension.
I4O. Several important health-related issues on the EC level are not being administered
by' the Community institutions themselves, but have become the task of
independent agencies. In this report, there have been references to the European
Agency for Safety and Health at Work.(Bilbao), the European Medicines
Evaluation Agency (Eln{E'A) in London, the European Environment Agency
(Copenhagen), and the European Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) in Lisbon. In their work, these agencies, while formally independent,
are still required to respect the provisions of Article 129 of the Treaty.
I4l. The emphasis which the first report put on the need for complementarity - public
health policy needs to be complementary to other policies, and other Community
policies may need to be complemented by public health measures - remains a
continual challenge for Community policiest2. Particularly in areas where the
legislative groundwork has been laid, it is important to realise that legislative or
- other measures in that context may also have important public health aspects
which need to be considered.
142. All in all, health protection and disease prevention requirements are steadily
taking on more importance both as a result of the consultation processes installed
inside the Commission - including the Interservice Group on Health - and because
of growing public awareness of the health implications of other areas of policy.
Report on the integration of health requirements in Community policies (1994), COM (95) 196 fin.
of 29.05.1995, p. 40f.
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143. This report is intended to be a contribution to the transparent functioning of the
Community. This is, however, a two-way process. The Commission would
therefore hope that the publication of this report will also provide important
pointers to all those involved and interested in decision-making in various policy
areas to ways and directions of intervention aiming at ensuring that health
requirements are properly integrated intb the various Community policies.
Article 129 of the Treaty places the obligation to integrate health requirements in
Community policies on all the institutions involved in the shaping and
implementation of Community policies Some Member States and regions in the
Community have launched similar initiatives. The Commission hopes that this
report will stimulate other Member States and regions to follow suit.
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ANNEX
Proposals for and adoption of major health-related legislation in 1995
Legislation proposed in 1995
Public health
Communication and Proposal for a European Parliament and Council Decision on Health
Monitoring, COM (95) 449 fin. of 16.10.1995
Social policy
Amended proposal for a Regulation amending Council Regulation (EEC) 1408/71, OJ C
242, t9.09.1995
Proposal for a Council Directive amending Directive 90/349|EEC on the protection of
workers from the risks related to the exposure to carcinogens at worlg OI C 317,
28. l 1.1995
Environment
Proposal for a European Parliament and Council Directive on the approximation of the
laws of the Member States relating to the measures to be taken against the emission of
gaseous and particulate pollutants from internal combustion engines to be installed in
non-road mobile machinery, COM (95) 350 fin. of 06.09.1995
Amended proposal for a Council Directive concerning integrated pollution prevention and
control, COM (95) 88 fin. of 15.05.1995
Amended proposal for a Council Directive on the marketing of biocidal products, COM
(9s) 387 fin. of 20.07.r99s
Agriculture
Proposal for a Council Directive in relation to the marketing of meat products, OJ C 269
of 16.10.1995
Proposal for a Council Directive amending Directive g2lllTIEEC concerning measures
for protection against certain zoonoses, COM (95) 491 lin. of 23.10.1995
Transport
Proposal for a Council Directive on maritime equipment, COM (95) 269 fin. of
2r.06.t99s
Proposal for a Council Directive on the approximation of laws of the Member States
relating to roadworthiness tests for motor vehicles and their trailers, COM (95) a15 fin.
of 08.09.1995
4"
Energt
proposal for a Council Decision concerning a m,ulti-annual programme for the qt9T9t]9i
of energy effrciency in the European Union - S/rVE II, COM (95) 225 fin. of 31.05. 1995
Legislation adoPted in 1995
Sociat policy
Medium-Term Social Action Programme, COII{ (95) 134 fin. of 12.04.1995
The Future of Social Protection - a framework fbr a European debate, COM (95) a66 fin.
of 31.10.1995
Commission Communication on a Community programme concerning safety, hygiene and
health at work (1996-2000I COM (95) 282 firr. of 12.07.1995
Commission Decision 95l230lEC of 12.07.199)5 setting up a Scientific Committee for
Occupational Exposure Limits to Chemical Agents, OJ L 188, 09.08.1995
Commission Decision gsl3lglEc of 12.07.1995 setting up a Committee of Senior Labour
Inspectors, OJ L 188, 09.08.1995
Single Market
lSth Directive adapting to technical progressi the annexes of the basic Directive on
cosmetics products, Commission Directive 9r5l34lBC of 10.07.1995, OI L 167 of
18.07.1995
6th Directive on methods of analysis for cheching the composition of cosmetic products,
Commission Directive 95l32lEC of 07.07.199:i, OI L 178, 28.07 -1995
Directive establishing the criteria and conditions under which a manufacturer may apply
not to include one or more ingredients on the list of ingredients to be indicated on the
packaging of cosmetic products, Commission Directive 95117/EC of 19.06.1995, OI L
140,23.06.1995
Directive 95/46lEC of the European Parliament and of the Council of 24.10.1995 on the
protection of individuals with regard to the processing of personal data and on the free
movement of such data, OJ L 281,23.11.199:i
Agriculture
Council Directive g5l23lEc of 22.06.1995 amending Directiv e 641433/EEC on conditions
for the produi:tion and marketing of fresh meat, OJ L 243, 11.10.1995
Council Directives harmonising maximum residue levels for nine pesticide active
substances and amending existing maximum residue levels for other pesticide active
substances, Council Directives 95/38tEC, OI L 197,22.08.1995; 95/39tEC, OI L 197,
22.08.1995;95l6llEC. OJ L 292, 07.12.1995
-so
Commission Directive gSt3tEC of 14.02.1995 amending Directive 90/128/EEC relating
to plastic materials and articles intended to come into contact with foodstuffs, OJ L 41,
23.02.1995
Commission Decision g5/492tEC of 15.11.1995 amendrng Decision g4/652tEC
establishing the inventory and distribution of tasks to be undertaken within the framework
of cooperation by Member States in the scientific examination of questions related to
food, OJ L 282,24.11.1995
Transport
Commission Communication on a common transport policy: AcJion programme 1995-
2000, COItd (95) 302 fin. of 12.07.r99s
Council Regulation @C) No 3051/95 of 08.12.1995 on the safety management of roll-
on/roll-off passenger ferries, OI L 320,30.12.1995
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